A nationwide study in Finland showed that the number of antibiotics and asthma drugs fell by 59.6% and 19.8%, respectively, from 2019 to 2020, generating millions in cost savings.
It is already known that the 2020 lockdown across many countries due to the global pandemic caused a drop in childhood infections. Researchers in Finland, in a recently published study, said that antibiotic and asthma prescriptions fell there as well, reducing reimbursement costs.
Researchers examined the quantity of systemic antibiotics and asthma medicines dispensed to children aged 0−12 years before and during the pandemic and analyzed the effect on reimbursement costs.
In Finland, all citizens receive free public health care and drugs are covered by partial or full reimbursement, depending on the medicine.
Data for 2019 and 2020 came from the national Finnish register of reimbursable prescriptions. Prescription rates per 1000 children were calculated for each quarter and compared using rate ratios and 95% confidence intervals.
For antibiotics, there were 331,857 dispensed prescriptions, 69.1% in 2019 and 30.9% in 2020. The most common antibiotic dispensed in 2019-2020 was amoxicillin (55.4%), and most antibiotics were dispensed in 2019. Prescriptions for all antibiotics dropped by 55.3% in 2020, with the largest decrease in macrolides (59.2%). The smallest was for cephalosporins.
The biggest reduction in macrolides was observed for children aged 0−5 years (59.6%, 95% CI, 60.9%−58.2%).
Total reimbursable expenses for antibiotics were €1.95 million (US$2.21 million) in 2020 and €4.3 million (US$4.88 million) in 2019, for a saving of €2.3 million (US$2.6 million) (54.5%).
For asthma, there were 337,911 asthma drugs dispensed in 2019 and 2020, with 55.5% in 2019 and 44.5% in 2020.
Asthma medicines decreased by 19.8%, mostly in the category of short-acting beta-agonists for children aged 0−5 years (35.2%, 95% CI 36.1%−34.2%). This suggests that there were lower rates of asthma exacerbations and wheezing episodes in early 2020, the researchers said.
Total reimbursable expenses in 2020 were €2.94 million (US$3.33 million) and €3.83 million (US$4.34 million) in 2019, down 23% to €0.88 million (US$998,337).
Taken together, the lower number of medications dispensed in both categories reduced reimbursement costs by €3.4 million (US$3.85 million) from 2019 to 2020.
The researchers also looked at primary care visits for children. While they fell from March to June 2020, they rebounded in August and overall were higher in 2020 than in 2019.
Even as primary care visits increased, the number of dispensed medications fell, suggesting that the lower number of antibiotics was due to lower infections and not from a barrier to care.
Reference
Haapanen M, Renko M, Artama M, Kuitunen I. Systemic antibiotics and asthma medicines dispensed to 0−12 year olds significantly decreased during the COVID-19 pandemic in 2020. Acta Paediatr. 2022;111:376-382. doi:10.1111/apa.16144
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More